Class information for: |
Basic class information |
| Class id | #P | Avg. number of references |
Database coverage of references |
|---|---|---|---|
| 16550 | 648 | 38.3 | 77% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
| 159 | 3 | MENOPAUSE//ISOFLAVONES//TAMOXIFEN | 61134 |
| 329 | 2 | TAMOXIFEN//ESTROGEN RECEPTOR//AROMATASE INHIBITORS | 18133 |
| 16550 | 1 | JIANGDA PATHOL//APOPTOTIC EFFECTS//BETA CX | 648 |
Terms with highest relevance score |
| rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|---|
| 1 | JIANGDA PATHOL | address | 141358 | 1% | 50% | 6 |
| 2 | APOPTOTIC EFFECTS | authKW | 62827 | 0% | 67% | 2 |
| 3 | BETA CX | authKW | 62827 | 0% | 67% | 2 |
| 4 | 3 3 DIINDOLYLYMETHANE | authKW | 47121 | 0% | 100% | 1 |
| 5 | 7 12 DIMETHYLBENZALPHAANTHRACENE DMBA | authKW | 47121 | 0% | 100% | 1 |
| 6 | ADROGEN RECEPTOR | authKW | 47121 | 0% | 100% | 1 |
| 7 | AFFILIATED LIAOYANG CENT HOSP | address | 47121 | 0% | 100% | 1 |
| 8 | AGE AT DELIVERY | authKW | 47121 | 0% | 100% | 1 |
| 9 | ALL UNION ONCOL | address | 47121 | 0% | 100% | 1 |
| 10 | BEEDS | authKW | 47121 | 0% | 100% | 1 |
Web of Science journal categories |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | Oncology | 7615 | 56% | 0% | 361 |
| 2 | Gastroenterology & Hepatology | 1111 | 13% | 0% | 85 |
| 3 | Public, Environmental & Occupational Health | 530 | 13% | 0% | 83 |
| 4 | Surgery | 89 | 8% | 0% | 55 |
| 5 | Pathology | 73 | 4% | 0% | 24 |
| 6 | Endocrinology & Metabolism | 54 | 5% | 0% | 31 |
| 7 | Obstetrics & Gynecology | 36 | 3% | 0% | 20 |
| 8 | Medicine, General & Internal | 14 | 4% | 0% | 26 |
| 9 | Medicine, Research & Experimental | 13 | 3% | 0% | 19 |
| 10 | Women’s Studies | 10 | 0% | 0% | 3 |
Address terms |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | JIANGDA PATHOL | 141358 | 1% | 50% | 6 |
| 2 | AFFILIATED LIAOYANG CENT HOSP | 47121 | 0% | 100% | 1 |
| 3 | ALL UNION ONCOL | 47121 | 0% | 100% | 1 |
| 4 | BIOMED SCI CLIN MED SCI | 47121 | 0% | 100% | 1 |
| 5 | BIOMED SEVILLA IBISCSICHUVR CARLOS 3 | 47121 | 0% | 100% | 1 |
| 6 | BREAST BIOL CANC UNITDISCIPLINE SURG | 47121 | 0% | 100% | 1 |
| 7 | CANC BIOL GRPDISCIPLINE SURG | 47121 | 0% | 100% | 1 |
| 8 | CANC PREVENT PUBL HLTH SCI | 47121 | 0% | 100% | 1 |
| 9 | CCPDD | 47121 | 0% | 100% | 1 |
| 10 | COLORECTAL PREVENT MED | 47121 | 0% | 100% | 1 |
Journals |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | CANCER CAUSES & CONTROL | 9015 | 4% | 1% | 25 |
| 2 | CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION | 4285 | 4% | 0% | 24 |
| 3 | EUROPEAN JOURNAL OF CANCER PREVENTION | 2741 | 2% | 1% | 10 |
| 4 | CANCER PREVENTION RESEARCH | 1876 | 1% | 1% | 7 |
| 5 | BRITISH JOURNAL OF CANCER | 1746 | 4% | 0% | 26 |
| 6 | INTERNATIONAL JOURNAL OF CANCER | 1427 | 4% | 0% | 25 |
| 7 | ANTICANCER RESEARCH | 1163 | 3% | 0% | 22 |
| 8 | JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY | 964 | 2% | 0% | 10 |
| 9 | DISEASES OF THE COLON & RECTUM | 854 | 2% | 0% | 12 |
| 10 | CANCER DETECTION AND PREVENTION | 736 | 1% | 0% | 5 |
Author Key Words |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | APOPTOTIC EFFECTS | 62827 | 0% | 67% | 2 | Search APOPTOTIC+EFFECTS | Search APOPTOTIC+EFFECTS |
| 2 | BETA CX | 62827 | 0% | 67% | 2 | Search BETA+CX | Search BETA+CX |
| 3 | 3 3 DIINDOLYLYMETHANE | 47121 | 0% | 100% | 1 | Search 3+3+DIINDOLYLYMETHANE | Search 3+3+DIINDOLYLYMETHANE |
| 4 | 7 12 DIMETHYLBENZALPHAANTHRACENE DMBA | 47121 | 0% | 100% | 1 | Search 7+12+DIMETHYLBENZALPHAANTHRACENE+DMBA | Search 7+12+DIMETHYLBENZALPHAANTHRACENE+DMBA |
| 5 | ADROGEN RECEPTOR | 47121 | 0% | 100% | 1 | Search ADROGEN+RECEPTOR | Search ADROGEN+RECEPTOR |
| 6 | AGE AT DELIVERY | 47121 | 0% | 100% | 1 | Search AGE+AT+DELIVERY | Search AGE+AT+DELIVERY |
| 7 | BEEDS | 47121 | 0% | 100% | 1 | Search BEEDS | Search BEEDS |
| 8 | BIOMARKERS AND MOLECULAR TARGETS | 47121 | 0% | 100% | 1 | Search BIOMARKERS+AND+MOLECULAR+TARGETS | Search BIOMARKERS+AND+MOLECULAR+TARGETS |
| 9 | CELL INVASION MOTILITY | 47121 | 0% | 100% | 1 | Search CELL+INVASION+MOTILITY | Search CELL+INVASION+MOTILITY |
| 10 | COLON CANCER LINE | 47121 | 0% | 100% | 1 | Search COLON+CANCER+LINE | Search COLON+CANCER+LINE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
| Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
|---|---|---|---|---|
| 1 | WILLIAMS, C , DILEO, A , NIV, Y , GUSTAFSSON, JA , (2016) ESTROGEN RECEPTOR BETA AS TARGET FOR COLORECTAL CANCER PREVENTION.CANCER LETTERS. VOL. 372. ISSUE 1. P. 48 -56 | 53 | 57% | 2 |
| 2 | FOSTER, PA , (2013) OESTROGEN AND COLORECTAL CANCER: MECHANISMS AND CONTROVERSIES.INTERNATIONAL JOURNAL OF COLORECTAL DISEASE. VOL. 28. ISSUE 6. P. 737 -749 | 59 | 57% | 11 |
| 3 | GREEN, J , CZANNER, G , REEVES, G , WATSON, J , WISE, L , RODDAM, A , BERAL, V , (2012) MENOPAUSAL HORMONE THERAPY AND RISK OF GASTROINTESTINAL CANCER: NESTED CASE-CONTROL STUDY WITHIN A PROSPECTIVE COHORT, AND META-ANALYSIS.INTERNATIONAL JOURNAL OF CANCER. VOL. 130. ISSUE 10. P. 2387-2396 | 35 | 74% | 27 |
| 4 | DELLUC, C , BENAMOUZIG, R , (2008) HORMONE REPLACEMENT THERAPY AND COLORECTAL CANCER.GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE. VOL. 32. ISSUE 1. P. 19-28 | 41 | 77% | 3 |
| 5 | CHARLTON, BM , WU, KN , ZHANG, XH , GIOVANNUCCI, EL , FUCHS, CS , MISSMER, SA , ROSNER, B , HANKINSON, SE , WILLETT, WC , MICHELS, KB , (2015) ORAL CONTRACEPTIVE USE AND COLORECTAL CANCER IN THE NURSES' HEALTH STUDY I AND II.CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. VOL. 24. ISSUE 8. P. 1214 -1221 | 34 | 76% | 1 |
| 6 | LU, YX , ODDSBERG, J , MARTLING, A , LAGERGREN, J , (2014) REPRODUCTIVE HISTORY AND RISK OF COLORECTAL ADENOCARCINOMA.EPIDEMIOLOGY. VOL. 25. ISSUE 4. P. 595 -604 | 32 | 80% | 3 |
| 7 | BARZI, A , LENZ, AM , LABONTE, MJ , LENZ, HJ , (2013) MOLECULAR PATHWAYS: ESTROGEN PATHWAY IN COLORECTAL CANCER.CLINICAL CANCER RESEARCH. VOL. 19. ISSUE 21. P. 5842-5848 | 37 | 55% | 32 |
| 8 | LIN, J , ZHANG, SMM , COOK, NR , MANSON, JE , BURING, JE , LEE, IM , (2007) ORAL CONTRACEPTIVES, REPRODUCTIVE FACTORS, AND RISK OF COLORECTAL CANCER AMONG WOMEN IN A PROSPECTIVE COHORT STUDY.AMERICAN JOURNAL OF EPIDEMIOLOGY. VOL. 165. ISSUE 7. P. 794-801 | 38 | 69% | 29 |
| 9 | MOROIS, S , FOURNIER, A , CLAVEL-CHAPELON, F , MESRINE, S , BOUTRON-RUAULT, MC , (2012) MENOPAUSAL HORMONE THERAPY AND RISKS OF COLORECTAL ADENOMAS AND CANCERS IN THE FRENCH E3N PROSPECTIVE COHORT: TRUE ASSOCIATIONS OR BIAS?.EUROPEAN JOURNAL OF EPIDEMIOLOGY. VOL. 27. ISSUE 6. P. 439-452 | 35 | 66% | 6 |
| 10 | CHARLTON, BM , GIOVANNUCCI, E , FUCHS, CS , CHAN, AT , LEE, JE , CAO, Y , MISSMER, SA , ROSNER, BA , HANKINSON, SE , WILLETT, W , ET AL (2016) A PROSPECTIVE STUDY OF ORAL CONTRACEPTIVE USE AND COLORECTAL ADENOMAS.CANCER CAUSES & CONTROL. VOL. 27. ISSUE 6. P. 749 -757 | 31 | 69% | 0 |
Classes with closest relation at Level 1 |